Urinary biomarkers reporting weakness and validation failure in Type 2 diabetic nephropathy: systematic review

被引：1
作者：
Siddiqui, Khalid [1 ]
Joy, Salini S. [1 ]
Ilias, Shumaila [1 ]
Alzeer, Haya S. [3 ]
Al-Rubeaan, Khalid [1 ,2 ]
机构：
[1] King Saud Univ, Dept Biochem, Strateg Ctr Diabet Res, Riyadh, Saudi Arabia
[2] King Saud Univ, Univ Diabet Ctr, Coll Med, Riyadh, Saudi Arabia
[3] King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia
来源：
BIOMARKERS IN MEDICINE | 2018年 / 12卷 / 05期
关键词：
diagnostic accuracy; markers; reporting quality; Type 2 diabetic nephropathy; urinary biomarkers; MONOCYTE CHEMOATTRACTANT PROTEIN-1; BETA-D-GLUCOSAMINIDASE; IV COLLAGEN; DIAGNOSTIC-ACCURACY; TUBULAR MARKERS; CYSTATIN C; RENAL INJURY; EARLY-STAGE; MELLITUS; ASSOCIATION;
D O I：
10.2217/bmm-2017-0338
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
For better identification of novel diagnostic urinary biomarker in Type 2 diabetic nephropathy (T2DN), methodological and reporting quality is as important as validity of biomarkers. The aim of this systematic review is to find out the best-reported diagnostic urinary biomarkers study in T2DN based on STARD criteria. We also analyzed the validity of urinary markers in the selected articles those followed STARD criteria. The diagnostic accuracy of urinary biomarkers on T2DN is not conclusive because of the poor reporting quality and differences in adjustment for conventional risk factors. For a proper validation of urinary biomarkers on T2DN, in future large well-designed longitudinal studies, with specific prediction analysis and validation of the biomarkers by adjusting with possible conventional risk factors.
引用
收藏
页码：487 / 499
页数：13
相关论文
共 75 条
[1]  
Al-Refai A A., 2014, Open Journal of Nephrology, V4, P37
[2]  
[Anonymous], 2015, IDF Diabetes Atlas, V7
[3]   Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria [J].
Araki, Shin-ichi ;
Haneda, Masakazu ;
Koya, Daisuke ;
Isshiki, Keiji ;
Kume, Shinji ;
Sugimoto, Toshiro ;
Kawai, Hiromichi ;
Nishio, Yoshihiko ;
Kashiwagi, Atsunori ;
Uzu, Takashi ;
Maegawa, Hiroshi .
DIABETES CARE, 2010, 33 (08) :1805-1810
[4]   Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus [J].
Assal, Heba S. ;
Tawfeek, Salwa ;
Rasheed, Enas A. ;
El-Lebedy, Dalia ;
Thabet, Eman H. .
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2013, 6 :7-13
[5]   PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts [J].
Beller, Elaine M. ;
Glasziou, Paul P. ;
Altman, Douglas G. ;
Hopewell, Sally ;
Bastian, Hilda ;
Chalmers, Iain ;
Gotzsche, Peter C. ;
Lasserson, Toby ;
Tovey, David .
PLOS MEDICINE, 2013, 10 (04)
[6]  
Bhattacharya A., 2005, MED UPDATE 2005, P263
[7]   Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients [J].
Bolignano, Davide ;
Lacquaniti, Antonio ;
Coppolino, Giuseppe ;
Donato, Valentina ;
Fazio, Maria Rosaria ;
Nicocia, Giacomo ;
Buemi, Michele .
KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (02) :91-98
[8]   STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies [J].
Bossuyt, Patrick M. ;
Reitsma, Johannes B. ;
Bruns, David E. ;
Gatsonis, Constantine A. ;
Glasziou, Paul P. ;
Irwig, Les ;
Lijmer, Jeroen G. ;
Moher, David ;
Rennie, Drummond ;
de Vet, Henrica C. W. ;
Kressel, Herbert Y. ;
Rifai, Nader ;
Golub, Robert M. ;
Altman, Douglas G. ;
Hooft, Lotty ;
Korevaar, Daniel A. ;
Cohen, Jeremie F. .
CLINICAL CHEMISTRY, 2015, 61 (12) :1446-1452
[9]   Interpreting diagnostic test accuracy studies [J].
Bossuyt, Patrick M. M. .
SEMINARS IN HEMATOLOGY, 2008, 45 (03) :189-195
[10]   DEFINING BIOMARKER PERFORMANCE AND CLINICAL VALIDITY [J].
Bossuyt, Patrick M. M. .
JOURNAL OF MEDICAL BIOCHEMISTRY, 2011, 30 (03) :193-200
12345678